$CPSS
Consumer Portfolio Services Inc Stock $cpss

$cpss Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000168316823003114 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$84.86M	$83.10M	$71.97M
YoY Change	3.46%	15.47%	6.62%
Cost Of Revenue	$35.71M	$32.76M	$16.40M
YoY Change	90.22%	99.75%	-21.53%
Gross Profit	$49.15M	$50.34M	$55.57M
YoY Change	-16.05%	-9.4%	19.24%
Gross Profit Margin	57.92%	60.58%	77.21%
Selling, General & Admin	$32.93M	$33.43M	$37.62M
YoY Change	133.25%	-11.14%	11.3%
% of Gross Profit	67.0%	66.41%	67.71%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$211.0K	$231.0K	$417.0K
YoY Change	-45.19%	-44.6%	4.25%
% of Gross Profit	0.43%	0.46%	0.75%
Operating Expenses	$30.55M	$31.91M	$28.64M
YoY Change	-36.09%	11.43%	-16.51%
Operating Profit	$18.60M	$18.43M	$26.93M
YoY Change	73.14%	-31.55%	118.93%
Interest Expense	$0.00	$0.00	$2.400M
YoY Change	-100.0%	-100.0%	-154.55%
% of Operating Profit	0.0%	0.0%	8.91%
Other Income/Expense, Net
YoY Change
Pretax Income	$18.60M	$18.43M	$29.33M
YoY Change	-45.63%	-37.16%	271.24%
Income Tax	$4.650M	$4.608M	$8.213M
% Of Pretax Income	24.99%	25.0%	28.0%
Net Earnings	$13.95M	$13.82M	$21.12M
YoY Change	-44.89%	-34.53%	306.06%
Net Earnings / Revenue	16.44%	16.63%	29.34%
Basic Earnings Per Share	$0.67	$0.68	$0.99
Diluted Earnings Per Share	$0.55	$0.54	$748.8K
COMMON SHARES
Basic Shares Outstanding	20.78M shares	20.54M shares	21.22K shares
Diluted Shares Outstanding	25.37M shares	25.39K shares	28.20K shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.081M	$10.19M	$21.73M
YoY Change	-37.6%	-53.11%	136.15%
Cash & Equivalents	$7.081M	$10.19M	$21.73M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$46.36M	$54.81M	$141.7M
Other Receivables	$0.00	$0.00	$1.673M
Total Short-Term Assets	$53.44M	$64.99M	$165.1M
YoY Change	-57.61%	-60.64%	-52.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.284M	$1.463M	$8.622M
YoY Change	-5.24%	-83.03%	-29.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$155.4M	$168.7M	$183.5M
YoY Change	537.74%	-8.05%	-1.84%
Total Long-Term Assets	$2.800B	$2.772B	$2.112B
YoY Change	17.94%	31.21%	21.04%
TOTAL ASSETS
Total Short-Term Assets	$53.44M	$64.99M	$165.1M
Total Long-Term Assets	$2.800B	$2.772B	$2.112B
Total Assets	$2.854B	$2.837B	$2.278B
YoY Change	14.13%	24.55%	8.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$57.38M	$59.83M	$48.46M
YoY Change	3.2%	23.45%	28.21%
Accrued Expenses	$5.271M	$5.154M	$7.684M
YoY Change	-15.16%	-32.93%	-27.51%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$57.38M	$59.83M	$56.15M
YoY Change	-7.17%	6.55%	16.0%
LONG-TERM LIABILITIES
Long-Term Debt	$2.541B	$2.534B	$2.038B
YoY Change	13.43%	24.37%	6.74%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$2.541B	$2.534B	$2.038B
YoY Change	13.43%	24.37%	6.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$57.38M	$59.83M	$56.15M
Total Long-Term Liabilities	$2.541B	$2.534B	$2.038B
Total Liabilities	$2.599B	$2.594B	$2.094B
YoY Change	12.88%	23.89%	6.97%
SHAREHOLDERS EQUITY
Retained Earnings	$230.3M	$216.3M
YoY Change	41.31%
Common Stock	$27.94M	$29.49M
YoY Change	-24.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$255.2M	$242.8M	$170.2M
YoY Change
Total Liabilities & Shareholders Equity	$2.854B	$2.837B	$2.278B
YoY Change	14.13%	24.55%	8.67%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$13.95M	$13.82M	$21.12M
YoY Change	-44.89%	-34.53%	306.06%
Depreciation, Depletion And Amortization	$211.0K	$231.0K	$417.0K
YoY Change	-45.19%	-44.6%	4.25%
Cash From Operating Activities	$55.52M	$65.14M	$68.30M
YoY Change	8.08%	-4.63%	4.43%
INVESTING ACTIVITIES
Capital Expenditures	$32.00K	$34.00K	-$275.0K
YoY Change	-104.25%	-112.36%	-31.25%
Acquisitions
YoY Change
Other Investing Activities	-$71.87M	-$121.1M	-$139.2M
YoY Change	-72.16%	-13.01%	-673.01%
Cash From Investing Activities	-$71.90M	-$121.2M	-$139.5M
YoY Change	-72.23%	-13.16%	-683.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.441M	$62.31M	80.95M
YoY Change	-98.71%	-23.02%	-224.92%
NET CHANGE
Cash From Operating Activities	55.52M	$65.14M	68.30M
Cash From Investing Activities	-71.90M	-$121.2M	-139.5M
Cash From Financing Activities	2.441M	$62.31M	80.95M
Net Change In Cash	-13.94M	$6.294M	9.728M
YoY Change	-22.16%	-35.3%	-60.29%
FREE CASH FLOW
Cash From Operating Activities	$55.52M	$65.14M	$68.30M
Capital Expenditures	$32.00K	$34.00K	-$275.0K
Free Cash Flow	$55.49M	$65.11M	$68.58M
YoY Change	6.46%	-5.06%	4.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10188000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13490000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	158895000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	149299000	usd
CY2023Q1	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	2575117000	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	2476617000	usd
CY2023Q1	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	69533000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	92304000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14728000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21753000	usd
CY2023Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	54805000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	70551000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1463000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1660000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	9792000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	10177000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	26362000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	30974000	usd
CY2023Q1	us-gaap	Assets Assets	2836622000	usd
CY2022Q4	us-gaap	Assets Assets	2752768000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	59825000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	55421000	usd
CY2023Q1	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	285809000	usd
CY2022Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	285328000	usd
CY2023Q1	cpss	Residual Interest Financing ResidualInterestFinancing	49686000	usd
CY2022Q4	cpss	Residual Interest Financing ResidualInterestFinancing	49623000	usd
CY2023Q1	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	2175068000	usd
CY2022Q4	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	2108744000	usd
CY2023Q1	us-gaap	Subordinated Debt SubordinatedDebt	23443000	usd
CY2022Q4	us-gaap	Subordinated Debt SubordinatedDebt	25263000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	2593831000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2524379000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4998130	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4998130	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20496144	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20496144	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20131323	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20131323	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	29485000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	28906000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	216337000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	202514000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3031000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3031000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	242791000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	228389000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2836622000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2752768000	usd
CY2023Q1	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	80062000	usd
CY2022Q1	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	70060000	usd
CY2023Q1	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	-0	usd
CY2022Q1	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	-2400000	usd
CY2023Q1	us-gaap	Other Operating Income OtherOperatingIncome	3038000	usd
CY2022Q1	us-gaap	Other Operating Income OtherOperatingIncome	1906000	usd
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89169
CY2023Q1	dei	City Area Code CityAreaCode	(949)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	753-6800
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, no par value
CY2023Q1	dei	Trading Symbol TradingSymbol	CPSS
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000889609
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2023Q1	cpss	Pension Benefit Obligation PensionBenefitObligation		usd
CY2022Q1	cpss	Pension Benefit Obligation PensionBenefitObligation		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	1-11416
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	CONSUMER PORTFOLIO SERVICES, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0459135
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3800 Howard Hughes Parkway
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1400
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Las Vegas
CY2023Q1	us-gaap	Revenues Revenues	83100000	usd
CY2022Q1	us-gaap	Revenues Revenues	74366000	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	22033000	usd
CY2022Q1	us-gaap	Salaries And Wages SalariesAndWages	22152000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11396000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8231000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	32759000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	16400000	usd
CY2023Q1	cpss	Provision For Credit Losses ProvisionForCreditLosses	-9000000	usd
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20777911	shares
CY2022Q1	cpss	Provision For Credit Losses ProvisionForCreditLosses	-9400000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5724000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5386000	usd
CY2023Q1	us-gaap	Occupancy Net OccupancyNet	1526000	usd
CY2022Q1	us-gaap	Occupancy Net OccupancyNet	1852000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	231000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	417000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	64669000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	45038000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	18431000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	29328000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4608000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8213000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	13823000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	21115000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.68
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.99
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20418	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21221	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25392	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28197	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	13823000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	21115000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-13823000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-21115000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	13823000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	21115000	usd
CY2023Q1	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	-47472000	usd
CY2022Q1	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	-31204000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	231000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	417000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2403000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1782000	usd
CY2023Q1	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	0	usd
CY2022Q1	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	-2400000	usd
CY2023Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-9000000	usd
CY2022Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-9400000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	912000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	790000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-385000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-662000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4511000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-10790000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4404000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	13340000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	65141000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	68300000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	-24746000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	-43840000	usd
CY2023Q1	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	352598000	usd
CY2022Q1	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	393407000	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	206626000	usd
CY2022Q1	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	209844000	usd
CY2023Q1	cpss	Change In Repossessions In Inventory ChangeInRepossessionsInInventory	-101000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	56500000	usd
CY2022Q1	cpss	Change In Repossessions In Inventory ChangeInRepossessionsInInventory	-481000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	275000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-121159000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-139517000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	324768000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	316800000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	1059000	usd
CY2023Q1	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	1820000	usd
CY2022Q1	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	762000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-7000	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	42170000	usd
CY2023Q1	cpss	Net Proceeds From Repayment Of Residual Interest Financing Debt NetProceedsFromRepaymentOfResidualInterestFinancingDebt	-0	usd
CY2022Q1	cpss	Net Proceeds From Repayment Of Residual Interest Financing Debt NetProceedsFromRepaymentOfResidualInterestFinancingDebt	4311000	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	258224000	usd
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	262737000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2072000	usd
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3030000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7293000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	14104000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6960000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5860000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	62312000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	80945000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6294000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	9728000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	162789000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	176548000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	169083000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186276000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	29658000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	14380000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	25000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	228389000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	242791000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	183868000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	43000000.0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3800000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	10200000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2661000	shares
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zl1Mc2wxFadi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_863_zAXGh311ihLf">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, as well as the reported amounts of income and expenses during the reported periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p>
CY2023Q1	us-gaap	Other Operating Income OtherOperatingIncome	3038000	usd
CY2022Q1	us-gaap	Other Operating Income OtherOperatingIncome	1906000	usd
CY2023Q1	cpss	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	28397000	usd
CY2022Q4	cpss	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	28397000	usd
CY2023Q1	cpss	Accumulated Amortization Rightofuse Assets AccumulatedAmortizationRightofuseAssets	-23611000	usd
CY2022Q4	cpss	Accumulated Amortization Rightofuse Assets AccumulatedAmortizationRightofuseAssets	-22613000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4786000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5784000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	5154000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6234000	usd
CY2023Q1	cpss	Finance Lease Right Of Use Asset At Cost FinanceLeaseRightOfUseAssetAtCost	3454000	usd
CY2022Q4	cpss	Finance Lease Right Of Use Asset At Cost FinanceLeaseRightOfUseAssetAtCost	3407000	usd
CY2023Q1	cpss	Finance Lease Right Of Use Asset Accumulated Depreciation FinanceLeaseRightOfUseAssetAccumulatedDepreciation	-3335000	usd
CY2022Q4	cpss	Finance Lease Right Of Use Asset Accumulated Depreciation FinanceLeaseRightOfUseAssetAccumulatedDepreciation	-3301000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	119000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	106000	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	125000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	177000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11167000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7770000	shares
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1360000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1761000	usd
CY2023Q1	cpss	Finance Lease Cost FinanceLeaseCost	101000	usd
CY2022Q1	cpss	Finance Lease Cost FinanceLeaseCost	298000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	1461000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	2059000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1360000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1788000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	99000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	282000	usd
CY2023Q1	cpss	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	2000	usd
CY2022Q1	cpss	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	16000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	912000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	790000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	8600000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M12D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10081000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6871000	shares
CY2023Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-9000000	usd
CY2022Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-9400000	usd
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_848_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zHDZMNsyJZu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_863_zvEM7rexX3Fi">Reclassifications</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Some items in the prior year financial statements were reclassified to conform to the current presentation. Reclassifications had no effect on net income or shareholders’ equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Interest Receivable InterestReceivable	69500000	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	92300000	usd
CY2023Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	69533000	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	92304000	usd
CY2023Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	1200000	usd
CY2022Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	2000000.0	usd
CY2023Q1	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	69533000	usd
CY2022Q4	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	92304000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21753000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	56206000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	14400000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	3018000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	5359000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	4993000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	3554000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14728000	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	45001000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	3018000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	5359000	usd
CY2023Q1	us-gaap	Other Foreclosed Assets OtherForeclosedAssets	1403000	usd
CY2022Q4	us-gaap	Other Foreclosed Assets OtherForeclosedAssets	1894000	usd
CY2023Q1	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-933000	usd
CY2022	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-1323000	usd
CY2023Q1	cpss	Other Foreclosed Assets Net OtherForeclosedAssetsNet	470000	usd
CY2022Q4	cpss	Other Foreclosed Assets Net OtherForeclosedAssetsNet	571000	usd
CY2023Q1	cpss	Receivables Pledged ReceivablesPledged	2345648000	usd
CY2023Q1	cpss	Securitization Trust Debt Initial Principal SecuritizationTrustDebtInitialPrincipal	5417405000	usd
CY2023Q1	us-gaap	Principal Amount Outstanding Of Loans Held In Portfolio PrincipalAmountOutstandingOfLoansHeldInPortfolio	2189463000	usd
CY2022Q4	us-gaap	Principal Amount Outstanding Of Loans Held In Portfolio PrincipalAmountOutstandingOfLoansHeldInPortfolio	2122919000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	644000000.0	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	659500000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	398900000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	239700000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	151800000	usd
CY2023Q1	cpss	Long Term Debt Maturities Repayments Of Principal In Year Six LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix	76000000.0	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	5200000	usd
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	6976	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25392	shares
CY2022Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	14200000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	158900000	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	361313000	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	363141000	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	4662000	usd
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	11314000	usd
CY2023Q1	us-gaap	Interest Income Purchased Receivables InterestIncomePurchasedReceivables	74058000	usd
CY2022Q1	us-gaap	Interest Income Purchased Receivables InterestIncomePurchasedReceivables	58740000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1342000	usd
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	6000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	80062000	usd
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	70060000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	32759000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	16400000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20418	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21221	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	4974	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28197	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1700000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	558000	shares
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	9800000	usd
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4600000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.25	pure
CY2022Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	8200000	usd
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.28	pure
CY2023Q1	cpss	Probable Losses For Legal Contingencies ProbableLossesForLegalContingencies	4900000	usd
CY2023Q1	cpss	Maximum Possible Losses For Legal Proceedings And Contingencies MaximumPossibleLossesForLegalProceedingsAndContingencies	11200000	usd
CY2022Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2476617000	usd
CY2021Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	1749098000	usd
CY2023Q1	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	352598000	usd
CY2022Q1	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	393407000	usd
CY2023Q1	cpss	Payments On Finance Receivables At Fair Value PaymentsOnFinanceReceivablesAtFairValue	-206626000	usd
CY2022Q1	cpss	Payments On Finance Receivables At Fair Value PaymentsOnFinanceReceivablesAtFairValue	-209844000	usd
CY2023Q1	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	-47472000	usd
CY2022Q1	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	-31204000	usd
CY2023Q1	cpss	Mark To Fair Value MarkToFairValue	0	usd
CY2022Q1	cpss	Mark To Fair Value MarkToFairValue	2400000	usd
CY2023Q1	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2575117000	usd
CY2022Q1	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	1903857000	usd
CY2023Q1	cpss	Finance Receivables Contractual Balance FinanceReceivablesContractualBalance	2810908000	usd
CY2023Q1	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2575117000	usd
CY2022Q4	cpss	Finance Receivables Contractual Balance FinanceReceivablesContractualBalance	2701184000	usd
CY2022Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2476617000	usd
CY2023Q1	cpss	Discount Rate On Finance Receivables DiscountRateOnFinanceReceivables	11.0% - 11.5%
CY2022	cpss	Discount Rate On Finance Receivables DiscountRateOnFinanceReceivables	11.0% - 11.3%
CY2023Q1	cpss	Cumulative Net Losses On Finance Receivables CumulativeNetLossesOnFinanceReceivables	10.0% - 20.5%
CY2022	cpss	Cumulative Net Losses On Finance Receivables CumulativeNetLossesOnFinanceReceivables	13.4% - 19.4%
CY2023Q1	cpss	Finance Receivables Measured At Fair Value FinanceReceivablesMeasuredAtFairValue	2810908000	usd
CY2022Q4	cpss	Finance Receivables Measured At Fair Value FinanceReceivablesMeasuredAtFairValue	2701184000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10188000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	158895000	usd
CY2023Q1	cpss	Finance Receivables Fair Value Disclosure FinanceReceivablesFairValueDisclosure	49104000	usd
CY2023Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	86000	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	285809000	usd
CY2023Q1	cpss	Residuals Interest Financing ResidualsInterestFinancing	49686000	usd
CY2023Q1	us-gaap	Accounts Payable Fair Value Disclosure AccountsPayableFairValueDisclosure	6888000	usd
CY2023Q1	us-gaap	Secured Debt SecuredDebt	2098717000	usd
CY2023Q1	us-gaap	Subordinated Debt SubordinatedDebt	23443000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13490000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	149299000	usd
CY2022Q4	cpss	Finance Receivables Fair Value Disclosure FinanceReceivablesFairValueDisclosure	60063000	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	649000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	285328000	usd
CY2022Q4	us-gaap	Accounts Payable Fair Value Disclosure AccountsPayableFairValueDisclosure	6190000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	1957995000	usd
CY2022Q4	us-gaap	Subordinated Debt SubordinatedDebt	25263000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
cpss-20230331_cal.xml	Edgar Link	unprocessable
0001683168-23-003114-index-headers.html	Edgar Link	pending
0001683168-23-003114-index.html	Edgar Link	pending
0001683168-23-003114.txt	Edgar Link	pending
0001683168-23-003114-xbrl.zip	Edgar Link	pending
cpss-20230331.xsd	Edgar Link	pending
cps_ex3101.htm	Edgar Link	pending
cps_ex3102.htm	Edgar Link	pending
cps_ex3200.htm	Edgar Link	pending
cps_i10q-033123.htm	Edgar Link	pending
cpss-20230331_def.xml	Edgar Link	unprocessable
cpss-20230331_lab.xml	Edgar Link	unprocessable
cpss-20230331_pre.xml	Edgar Link	unprocessable
cps_i10q-033123_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPSS
Consumer Portfolio Services Inc Stock $cpss

2023 Q2 Form 10-Q Financial Statement

#000168316823003114 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSS Consumer Portfolio Services Inc Stock $cpss

2023 Q2 Form 10-Q Financial Statement

#000168316823003114 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSS
Consumer Portfolio Services Inc Stock $cpss